SEC Info - Hollingsworth Jane H - ‘4’ for 8/31/22 re: Diffusion Pharmaceuticals Inc.

SEC Info℠

Home

Help

Please Sign In

Hollingsworth Jane H – ‘4’ for 8/31/22 re: Diffusion Pharmaceuticals Inc.

On: Friday, 9/2/22, at 9:06pm ET · For: 8/31/22 · As: Director · Accession #: 1437749-22-21841 · File #: 1-37942

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 9/02/22  Hollingsworth Jane H              4          Director    1:7K   Diffusion Pharmaceuticals Inc.    RDG Filings/FA

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 4           Statement of Changes in Beneficial Ownership of     HTML      8K 
                Securities by an Insider -- rdgdoc.xml/3.6

Filing Submission 0001437749-22-021841 – SGML Text

Original SGML Text submitted by:	RDG Filings/FA (as Filing Agent)

To view the SGML, please refresh
this page.

↑Top

Hollingsworth Jane H – ‘4’ for 8/31/22 re: Diffusion Pharmaceuticals Inc.

On: Friday, 9/2/22, at 9:06pm ET · For: 8/31/22 · As: Director · Accession #: 1437749-22-21841 · File #: 1-37942

Previous ‘4’: ‘4’ on 6/2/22 for 5/31/22 · Next: ‘4’ on 12/2/22 for 11/30/22 · Latest: ‘4’ on / for 9/15/23

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34Filing Table of Contents

To view the SGML, please refresh this page.

Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 — SEA’34

Filing Table of Contents

To view the SGML, please refresh
this page.